CVN-424

DB18958InvestigationalSmall molecule

CVN-424 is under investigation in clinical trial NCT06006247 (Early Parkinson's Disease Monotherapy With CVN424).

Chemical structure of CVN-424
Formula / weight
C24H29F2N5O3 · 473.525 g/mol (avg)
Also known as
ETHANONE, 1-(2-(4-(2,4-DIFLUOROPHENOXY)-1-PIPERIDINYL)-7,8-DIHYDRO-3-(((3R)-TETRAHYDRO-3-FURANYL)AMINO)PYRIDO(3,4-B)PYRAZIN-6(5H)-YL)-
Code names
CVN-424

Resolves to

Compound
UNIIXO01711URGCAS2254706-21-1ChEMBLCHEMBL4778540
Structure
InChIKeyHSWVJQBEXRKOBZ-QGZVFWFLSA-NSMILESCC(=O)N1CCC2=NC(N3CCC(CC3)OC3=CC=C(F)C=C3F)=C(N[C@@H]3CCOC3)N=C2C1
Targets
P46095GPR6

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with CVN-424, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In